Identification of Six N7-Methylguanosine-Related miRNA Signatures to Predict the Overall Survival and Immune Landscape of Triple-Negative Breast Cancer through In Silico Analysis

Figure 4

Prognostic value of the risk model in the training, testing, and total sets. (a–c) OS analyses of the risk model. (d–f) ROC curves for TNBC survival rates at 1, 3, and 5 years. (g–i) The distribution of patients’ risk scores. (j–l) Survival time and status of patients.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)